Antigen Swab Test Kit

Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Date sheet Product

70mm 99% Accuracy SARS-CoV-2 Antigen Test Set Nasopharyngeal Swab 1 piece Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Date sheet Product name 70mm 99%

Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Date sheet Product name 70mm

70mm 2 years Shelf Life SARS-CoV-2 Antigen Test Set Nasopharyngeal Swab 1 piece Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Date sheet Product name 70mm

Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Date sheet Product name 70mm CE SARS-CoV-2

Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Date sheet Product name

Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Date sheet Product name 70mm

Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Date sheet Product name 99%

Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Date sheet

Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Date sheet Product name 99%

Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Date sheet

Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Date sheet Product

Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Date sheet Product

Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Date sheet Product name Plastic CE

Plastic Rapid Home Antigen Swab Test CE ISO:13485 Class I​II COVID-19 Antigen Rapid Test Principle The coronavirus antigen rapid test kit is a lateral flow assay that qualitatively detects the presence of nucleocapsid (N) protein in upper respiratory samples (nasal swabs). This lateral flow assay is designed with the sandwich immunoassay format. When the specimen is added onto the sample pad of a test cassette, coronavirus N protein binds with colloidal gold-labeled SARS-CoV

SARS-CoV-2 Antigen Test Set Nasopharyngeal Swab Malaysia 1 test/box Description COVID-19 is an infectious disease caused by a new coronavirus that can spread from person to person. COVID-19 symptoms can range from mild (or no symptoms) to severe illness. The Coronavirus (COVID-19) Antigen Rapid Test Cassette (Swab) is an in vitro immunochromatographic assay for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 virus in nasopharyngeal (NP) swab

Class III 99% Accuracy SARS-CoV-2 Antigen Test Set Nasopharyngeal Swab Malaysia 1 test/box Antigen Nasal or Throat Swab Rapid Lateral Flow Test Kit tells you if you currently have Covid-19 or not, with or without symptoms Immediate results within 15 minutes - significant time and cost savings over lab methods Easy to use and read - no specialist equipment needed Cassette test using nasopharyngeal swab/oropharyngeal swab CE Certified Description Viral antigen rapid test kit

Class III CE SARS-CoV-2 Antigen Test Set Nasopharyngeal Swab Malaysia 1 test/box Protect your workforce Rapidly test symptomatic staff for coronavirus without having to rely on government testing. Regular testing of staff without symptoms to pick up coronavirus infection early and minimise contact with other staff who may have to isolate too. Description Viral antigen rapid test kit for the detection of SARS-CoV-2 in human oropharyngeal, nasal, and nasopharyngeal swabs. The

Class III Fast reaction rapid SARS-CoV-2 Antigen Test Set Nasopharyngeal Swab Malaysia 1 test/box Features 15-minute rapid detection Easy-to-operate coronavirus antigen test Less-invasive nasal (NS) swab sample collection CE-IVD marked Available in 1/2/5/20 tests/box Nasopharyngeal swab and saliva versions available The latest innovation in coronavirus testing allows detection of current coronavirus infection from a swab or saliva sample in minutes. No laboratory analysis is

Class III Factory price SARS-CoV-2 Antigen Test Set Nasopharyngeal Swab Malaysia 1 test/box Description Viral antigen rapid test kit for the detection of SARS-CoV-2 in human oropharyngeal, nasal, and nasopharyngeal swabs. The test is a lateral flow assay with a colloidal gold reporter, giving results in ten minutes. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Rapid diagnosis of SARS-CoV-2 infection will help healthcare